167 related articles for article (PubMed ID: 30023485)
1. Structure-Activity Relationships of Cbx7 Inhibitors, Including Selectivity Studies against Other Cbx Proteins.
Simhadri C; Gignac MC; Anderson CJ; Milosevich N; Dheri A; Prashar N; Flemmer RT; Dev A; Henderson TG; Douglas SF; Wulff JE; Hof F
ACS Omega; 2016 Oct; 1(4):541-551. PubMed ID: 30023485
[TBL] [Abstract][Full Text] [Related]
2. Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7).
Simhadri C; Daze KD; Douglas SF; Quon TT; Dev A; Gignac MC; Peng F; Heller M; Boulanger MJ; Wulff JE; Hof F
J Med Chem; 2014 Apr; 57(7):2874-83. PubMed ID: 24625057
[TBL] [Abstract][Full Text] [Related]
3. The molecular selectivity of UNC3866 inhibitor for Polycomb CBX7 protein from molecular dynamics simulation.
Liu H; Li Z; Li L
Comput Biol Chem; 2018 Jun; 74():339-346. PubMed ID: 29723807
[TBL] [Abstract][Full Text] [Related]
4. Selective Inhibition of CBX6: A Methyllysine Reader Protein in the Polycomb Family.
Milosevich N; Gignac MC; McFarlane J; Simhadri C; Horvath S; Daze KD; Croft CS; Dheri A; Quon TT; Douglas SF; Wulff JE; Paci I; Hof F
ACS Med Chem Lett; 2016 Feb; 7(2):139-44. PubMed ID: 26985288
[TBL] [Abstract][Full Text] [Related]
5. Optimization of Ligands Using Focused DNA-Encoded Libraries To Develop a Selective, Cell-Permeable CBX8 Chromodomain Inhibitor.
Wang S; Denton KE; Hobbs KF; Weaver T; McFarlane JMB; Connelly KE; Gignac MC; Milosevich N; Hof F; Paci I; Musselman CA; Dykhuizen EC; Krusemark CJ
ACS Chem Biol; 2020 Jan; 15(1):112-131. PubMed ID: 31755685
[TBL] [Abstract][Full Text] [Related]
6. Prognostic values of distinct CBX family members in breast cancer.
Liang YK; Lin HY; Chen CF; Zeng D
Oncotarget; 2017 Nov; 8(54):92375-92387. PubMed ID: 29190923
[TBL] [Abstract][Full Text] [Related]
7. Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment, cancer and development.
van Wijnen AJ; Bagheri L; Badreldin AA; Larson AN; Dudakovic A; Thaler R; Paradise CR; Wu Z
Bone; 2021 Feb; 143():115659. PubMed ID: 32979540
[TBL] [Abstract][Full Text] [Related]
8. A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation.
Wang S; Alpsoy A; Sood S; Ordonez-Rubiano SC; Dhiman A; Sun Y; Jiao G; Krusemark CJ; Dykhuizen EC
Chembiochem; 2021 Jul; 22(13):2335-2344. PubMed ID: 33950564
[TBL] [Abstract][Full Text] [Related]
9. Single Nucleotide Polymorphisms of
Tan C; Bei C; Zhu X; Zhang Y; Qin L; Tan S
Biomed Res Int; 2019; 2019():6436825. PubMed ID: 31211140
[TBL] [Abstract][Full Text] [Related]
10. Identification of the Roles of Chromobox Family Members in Gastric Cancer: A Study Based on Multiple Datasets.
Chen ZY; Sun SX; Zhu SX; Bu J
Biomed Res Int; 2020; 2020():5306509. PubMed ID: 33344640
[TBL] [Abstract][Full Text] [Related]
11. Synthetic trimethyllysine receptors that bind histone 3, trimethyllysine 27 (H3K27me3) and disrupt its interaction with the epigenetic reader protein CBX7.
Tabet S; Douglas SF; Daze KD; Garnett GA; Allen KJ; Abrioux EM; Quon TT; Wulff JE; Hof F
Bioorg Med Chem; 2013 Nov; 21(22):7004-10. PubMed ID: 24100156
[TBL] [Abstract][Full Text] [Related]
12. Pan-specific and partially selective dye-labeled peptidic inhibitors of the polycomb paralog proteins.
Milosevich N; McFarlane J; Gignac MC; Li J; Brown TM; Wilson CR; Devorkin L; Croft CS; Hof R; Paci I; Lum JJ; Hof F
Bioorg Med Chem; 2020 Jan; 28(1):115176. PubMed ID: 31753799
[TBL] [Abstract][Full Text] [Related]
13. Structure-Guided Discovery of Selective Antagonists for the Chromodomain of Polycomb Repressive Protein CBX7.
Ren C; Smith SG; Yap K; Li S; Li J; Mezei M; Rodriguez Y; Vincek A; Aguilo F; Walsh MJ; Zhou MM
ACS Med Chem Lett; 2016 Jun; 7(6):601-5. PubMed ID: 27326334
[TBL] [Abstract][Full Text] [Related]
14. CBX Family Members in Two Major Subtypes of Renal Cell Carcinoma: A Comparative Bioinformatic Analysis.
Grimaldi AM; Affinito O; Salvatore M; Franzese M
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292141
[TBL] [Abstract][Full Text] [Related]
15. Live-cell single-molecule tracking reveals co-recognition of H3K27me3 and DNA targets polycomb Cbx7-PRC1 to chromatin.
Zhen CY; Tatavosian R; Huynh TN; Duc HN; Das R; Kokotovic M; Grimm JB; Lavis LD; Lee J; Mejia FJ; Li Y; Yao T; Ren X
Elife; 2016 Oct; 5():. PubMed ID: 27723458
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer.
Li X; Gou J; Li H; Yang X
Sci Rep; 2020 Oct; 10(1):17739. PubMed ID: 33082469
[TBL] [Abstract][Full Text] [Related]
17. Robustness of In Vitro Selection Assays of DNA-Encoded Peptidomimetic Ligands to CBX7 and CBX8.
Denton KE; Wang S; Gignac MC; Milosevich N; Hof F; Dykhuizen EC; Krusemark CJ
SLAS Discov; 2018 Jun; 23(5):417-428. PubMed ID: 29309209
[TBL] [Abstract][Full Text] [Related]
18. Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer.
Iqbal MA; Siddiqui S; Ur Rehman A; Siddiqui FA; Singh P; Kumar B; Saluja D
Mol Oncol; 2021 May; 15(5):1450-1465. PubMed ID: 33400401
[TBL] [Abstract][Full Text] [Related]
19. Polycomb Paralog Chromodomain Inhibitors Active against Both CBX6 and CBX8*.
Milosevich N; Wilson CR; Brown TM; Alpsoy A; Wang S; Connelly KE; Sinclair KAD; Ponio FR; Hof R; Dykhuizen EC; Hof F
ChemMedChem; 2021 Oct; 16(19):3027-3034. PubMed ID: 34174168
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain.
Ren C; Morohashi K; Plotnikov AN; Jakoncic J; Smith SG; Li J; Zeng L; Rodriguez Y; Stojanoff V; Walsh M; Zhou MM
Chem Biol; 2015 Feb; 22(2):161-8. PubMed ID: 25660273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
